The global Preterm Birth And PROM Testing Market size is expected to reach USD 1.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.0% from 2021 to 2028. Key factors that can be attributed to market growth are rising number of preterm births in developed and emerging economies, improving access to advanced neonatal and maternal care facilities, and introduction of new POC diagnostic products over the forecast period.
Preterm births are not specific to a particular geography
and have been recognized as a worldwide concern. The risk of preterm births
typically escalates with increasing average age of pregnant women. With growing
awareness about preterm births and its consequence, the tendency of pregnant
women to enroll for Premature Rupture of Membranes (PROM) testing during their
pregnancy is anticipated to increase, for reassurance and monitoring of
symptoms of preterm birth.
Point-of-Care (POC) diagnostics have drastically altered
the methodology of testing in various fields. With the help of advanced
technology, devices are able to assess analytes in a given sample. Companies
are focusing on R&D to increase specificity and sensitivity of devices,
which lowers the error rate. Hence, emphasis is being given to reducing sample
size required for other medical testing.
Many low-income states like Bihar, Madhya Pradesh,
Rajasthan, and Uttar Pradesh have low utilization of public healthcare services
for female infants. Despite the availability of free healthcare services, only
approximately 41% of admissions to the SNCUs are female infants. Hence, many
states have banned gender revelation to the family before birth. India is the
only large country where more female infants die than males. UNICEF plans to
intervene by strengthening the health infrastructure, and reducing inequities
of healthcare services, and improve healthcare outcomes.
Related Press
Release@ Preterm
Birth And PROM Testing Market Report
Preterm Birth And PROM Testing Market Report Highlights
- By
test type, the ultrasound segment dominated the market in 2020, as it is
one of the most preferred technologies for tracking fetal development and
maternal health
- Techniques
such as Placental Alpha-Microglobulin-1 (PAMG-1) are gaining prominence
due to better reliability in predicting the risk of preterm births
- North
America held the largest revenue share in 2020 owing to higher incidence
of pregnancies in the above 35 years age group and well-developed
infrastructure to manage high-risk pregnancies
- As
per the American College of Obstetricians and Gynecologists (ACOG), in the
U.S., nearly 12.0% of childbirths are preterm, which lead to higher
hospitalization and treatment costs
- In
Asia Pacific, the market is projected to witness the highest CAGR over the
forecast period. This can be attributed to high population growth in
countries such as India and China
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment